CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy
2012 · European Journal of Nuclear Medicine and Molecular Imaging · 55 citations
https://doi.org/10.1007/s00259-012-2242-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
227
Citations
3
h-index
1
i10-index
Ching-Sheng Liu is an academic researcher from Taipei Veterans General Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Advanced Radiotherapy Techniques & Lung Cancer Diagnosis and Treatment. The author has an h-index of 3, co-authored 4 publications.
Click to start Chat